RxDoctor Payments Data

Maged Ghali, MD

Gastroenterology · Jacksonville, FLNPI 1629404181

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,713 of the $2,892 with a category attached, or 93.8%. Novo Nordisk accounts for 93.8% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.

$2,892in general payments, 2019–2025

Across 2 payments — averaging $1446.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Medtronic$180
$460,976in research payments, 2019–2025

Across 108 payments — averaging $4268.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$309K
  • Intercept Pharma Europe Ltd.$42K
  • E.r. Squibb & Sons, L.L.C.$41K
  • Mirum Pharmaceuticals, Inc.$40K
  • Gilead$19K
  • Pfizer$10K

What the payments were for

  • Consulting fees$2,71394%
  • Food & beverage$1806%

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk1$2,713
Medtronic1$180

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,892 in reported general payments places this provider in the 45th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024
$19,637
Medicare patients
121
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin36$115,613
VemlidyTenofovir Alafenamide18$37,951
Tacrolimus17$1,285
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl67$1,034
Pantoprazole Sodium29$354
Carvedilol31$350
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl23$342
Esomeprazole Magnesium16$219
Furosemide12$95

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →